So when are our doctors going to put 2 and 2 together and give curcumin to us as a neuroprotective in the first days as listed here:
http://oc1dean.blogspot.com/2011/03/tumeric-and-stroke-rehab.html
The delivery article here:
http://www.dovepress.com/article_11689.t14230688
Abstract: We investigated
flexible liposomes as a potential oral drug delivery system. However,
enhanced membrane fluidity and structural deformability may necessitate
liposomal surface modification when facing the harsh environment of the
gastrointestinal tract. In the present study, silica-coated flexible
liposomes loaded with curcumin (CUR-SLs) having poor water solubility as
a model drug were prepared by a thin-film method with homogenization,
followed by the formation of a silica shell by the sol-gel process. We
systematically investigated the physical properties, drug release
behavior, pharmacodynamics, and bioavailability of CUR-SLs. CUR-SLs had a
mean diameter of 157 nm and a polydispersity index of 0.14, while the
apparent entrapment efficiency was 90.62%. Compared with curcumin-loaded
flexible liposomes (CUR-FLs) without silica-coatings, CUR-SLs had
significantly higher stability against artificial gastric fluid and
showed more sustained drug release in artificial intestinal fluid as
determined by in vitro release assays. The bioavailability of CUR-SLs
and CUR-FLs was 7.76- and 2.35-fold higher, respectively, than that of
curcumin suspensions. Silica coating markedly improved the stability of
flexible liposomes, and CUR-SLs exhibited a 3.31-fold increase in
bioavailability compared with CUR-FLs, indicating that silica-coated
flexible liposomes may be employed as a potential carrier to deliver
drugs with poor water solubility via the oral route with improved
bioavailability.
No comments:
Post a Comment